Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis

Completed · Phase 4

Conditions studied: Hand Dermatosis

In brief

The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.

Key facts

Study ID

NCT00828464

Run by

Stiefel, a GSK Company

People needed

30

Starts

2008-10-01

Expected to finish

2009-01-01

Last updated by the study team

2012-10-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects 18 years of age or older, with diagnosis of chronic dermatitis, able to complete the study and comply with study instructions.
• Female subjects of childbearing potential must have a negative pregnancy test. Sexually active women of childbearing potential participating in the study must have been using a medically acceptable form of contraception

You may not qualify if…

• Use of systemic corticosteroid and/or other prohibited medications within 4 weeks of the baseline visit.
• Use of topical corticosteroid therapy and/or other prohibited topical medications within 2 weeks prior to the baseline visit

Where it is running

• Physicians Skin Care — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.